These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 8384261

  • 1. Immunogenicity and efficacy of a commercial feline leukemia virus vaccine.
    Pedersen NC.
    J Vet Intern Med; 1993; 7(1):34-9. PubMed ID: 8384261
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of efficacy and safety of an inactivated virus vaccine against feline leukemia virus infection.
    Hines DL, Cutting JA, Dietrich DL, Walsh JA.
    J Am Vet Med Assoc; 1991 Nov 15; 199(10):1428-30. PubMed ID: 1666097
    [Abstract] [Full Text] [Related]

  • 3. Protection against feline leukemia virus infection by use of an inactivated virus vaccine.
    Hoover EA, Perigo NA, Quackenbush SL, Mathiason-DuBard CK, Overbaugh JM, Kloetzer WS, Elder JH, Mullins JI.
    J Am Vet Med Assoc; 1991 Nov 15; 199(10):1392-401. PubMed ID: 1666090
    [Abstract] [Full Text] [Related]

  • 4. Vaccination of cats experimentally infected with feline immunodeficiency virus, using a recombinant feline leukemia virus vaccine.
    Lehmann R, Franchini M, Aubert A, Wolfensberger C, Cronier J, Lutz H.
    J Am Vet Med Assoc; 1991 Nov 15; 199(10):1446-52. PubMed ID: 1666101
    [Abstract] [Full Text] [Related]

  • 5. Comparative efficacy of three commercial feline leukemia virus vaccines against methylprednisolone acetate-augmented oronasal challenge exposure with virulent virus.
    Pedersen NC, Johnson L.
    J Am Vet Med Assoc; 1991 Nov 15; 199(10):1453-5. PubMed ID: 1666102
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the efficacy of three commercial feline leukemia virus vaccines in a natural challenge exposure.
    Legendre AM, Hawks DM, Sebring R, Rohrbach B, Chavez L, Chu HJ, Acree WM.
    J Am Vet Med Assoc; 1991 Nov 15; 199(10):1456-62. PubMed ID: 1666103
    [Abstract] [Full Text] [Related]

  • 7. Study of feline leukemia virus immunity.
    Charreyre C, Pedersen NC.
    J Am Vet Med Assoc; 1991 Nov 15; 199(10):1316-24. PubMed ID: 1666074
    [Abstract] [Full Text] [Related]

  • 8. Protection against feline leukemia virus challenge for at least 2 years after vaccination with an inactivated feline leukemia virus vaccine.
    Jirjis FF, Davis T, Lane J, Carritt K, Sweeney D, Williams J, Wasmoen T.
    Vet Ther; 2010 Nov 15; 11(2):E1-6. PubMed ID: 20957616
    [Abstract] [Full Text] [Related]

  • 9. Recombinant FeLV vaccine: long-term protection and effect on course and outcome of FIV infection.
    Hofmann-Lehmann R, Holznagel E, Aubert A, Ossent P, Reinacher M, Lutz H.
    Vet Immunol Immunopathol; 1995 May 15; 46(1-2):127-37. PubMed ID: 7618252
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of an inactivated FeLV vaccine compared to a recombinant FeLV vaccine in minimum age cats following virulent FeLV challenge.
    Stuke K, King V, Southwick K, Stoeva MI, Thomas A, Winkler MT.
    Vaccine; 2014 May 07; 32(22):2599-603. PubMed ID: 24662705
    [Abstract] [Full Text] [Related]

  • 11. Possible immunoenhancement of persistent viremia by feline leukemia virus envelope glycoprotein vaccines in challenge-exposure situations where whole inactivated virus vaccines were protective.
    Pedersen NC, Johnson L, Birch D, Theilen GH.
    Vet Immunol Immunopathol; 1986 Feb 07; 11(2):123-48. PubMed ID: 3008409
    [Abstract] [Full Text] [Related]

  • 12. Antibody response of kittens after vaccination followed by exposure to feline leukemia virus-infected cats.
    Hawks DM, Legendre AM, Rohrbach BW, Sebring R, Chavez L, Chu HJ, Acree WM.
    J Am Vet Med Assoc; 1991 Nov 15; 199(10):1463-9. PubMed ID: 1666104
    [Abstract] [Full Text] [Related]

  • 13. Protection from challenge following administration of a canarypox virus-vectored recombinant feline leukemia virus vaccine in cats previously vaccinated with a killed virus vaccine.
    Grosenbaugh DA, Leard T, Pardo MC.
    J Am Vet Med Assoc; 2006 Mar 01; 228(5):726-7. PubMed ID: 16506935
    [Abstract] [Full Text] [Related]

  • 14. Anti-SU Antibody Responses in Client-Owned Cats Following Vaccination against Feline Leukaemia Virus with Two Inactivated Whole-Virus Vaccines (Fel-O-Vax® Lv-K and Fel-O-Vax® 5).
    Westman M, Norris J, Malik R, Hofmann-Lehmann R, Parr YA, Armstrong E, McDonald M, Hall E, Sheehy P, Hosie MJ.
    Viruses; 2021 Feb 03; 13(2):. PubMed ID: 33546485
    [Abstract] [Full Text] [Related]

  • 15. Development and testing of an inactivated feline leukemia virus vaccine.
    Hoover EA, Mullins JI, Chu HJ, Wasmoen TL.
    Semin Vet Med Surg Small Anim; 1995 Nov 03; 10(4):238-43. PubMed ID: 8820598
    [Abstract] [Full Text] [Related]

  • 16. Induction of protective immune response in cats by vaccination with feline leukemia virus iscom.
    Osterhaus A, Weijer K, Uytdehaag F, Jarrett O, Sundquist B, Morein B.
    J Immunol; 1985 Jul 03; 135(1):591-6. PubMed ID: 2987351
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety field trials of a recombinant DNA vaccine against feline leukemia virus infection.
    Clark N, Kushner NN, Barrett CB, Kensil CR, Salsbury D, Cotter S.
    J Am Vet Med Assoc; 1991 Nov 15; 199(10):1433-43. PubMed ID: 1666099
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.